Cigna Plans to Limit Out-Of-Pocket Drug Costs for US Patients

Cigna Group plans to limit patients’ out-of-pocket expenses for medications as the insurer faces pressure from Washington over its role in prescription costs.

The changes aim to ensure that patients don’t pay the drug company’s list price for medications and don’t pay more out-of-pocket for their medications than the amount that their employer contributes, a top executive said in an interview with Bloomberg News.

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over prescription drug costs. President Donald Trump in December said he wanted to “knock out the middleman” in drug purchasing, but lawmakers ...